| scholarly article | Q13442814 |
| P50 | author | Pamela Y Collins | Q47451434 |
| P2093 | author name string | Sarah S Joestl | |
| Leopoldo J Cabassa | |||
| Roberto Lewis-Fernández | |||
| Hannah Carliner | |||
| Ann McNallen | |||
| P2860 | cites work | Categorization of humans in biomedical research: genes, race and disease | Q21999793 |
| Racial residential segregation: a fundamental cause of racial disparities in health | Q24550668 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Quality of medical care and excess mortality in older patients with mental disorders | Q28184670 | ||
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
| Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases | Q30685350 | ||
| Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. | Q31005227 | ||
| Embodying inequality: a review of concepts, measures, and methods for studying health consequences of discrimination | Q33668263 | ||
| Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? | Q33707663 | ||
| Causes of the excess mortality of schizophrenia | Q33922258 | ||
| Consensus development conference on antipsychotic drugs and obesity and diabetes | Q34293049 | ||
| Physical health monitoring of patients with schizophrenia | Q34337506 | ||
| Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia | Q34630594 | ||
| Racial and ethnic differences in patient perceptions of bias and cultural competence in health care | Q34731586 | ||
| Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 | ||
| Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia | Q34769186 | ||
| Racial and ethnic differences in diabetes mellitus among people with and without psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34995920 | ||
| Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states | Q35024510 | ||
| Cigarette smoking and mortality risk in people with schizophrenia | Q35065406 | ||
| A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness | Q35185643 | ||
| Prevalence of metabolic syndrome in a predominantly cuban, psychiatrically ill, and homeless population | Q35251956 | ||
| HIV patients with psychiatric disorders are less likely to discontinue HAART. | Q35545476 | ||
| Diabetes in the Hispanic or Latino population: genes, environment, culture, and more | Q36147441 | ||
| Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities | Q36234930 | ||
| Atypical antipsychotic drugs, diabetes and ethnicity | Q36299999 | ||
| Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective | Q36567074 | ||
| Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study | Q36714070 | ||
| Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine | Q36866512 | ||
| Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness | Q36905098 | ||
| Health care for patients with serious mental illness: family medicine's role | Q37155948 | ||
| Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia | Q37162718 | ||
| A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study | Q37178699 | ||
| Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States | Q37182977 | ||
| General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. | Q37213547 | ||
| Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population | Q37292361 | ||
| Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health | Q37299954 | ||
| Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis | Q37309723 | ||
| Co-occurrence of mental and physical illness in US Latinos | Q37470951 | ||
| Smoking and mental illness: A population-based prevalence study | Q39513259 | ||
| The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders | Q40268199 | ||
| Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications | Q40417468 | ||
| Schizophrenia and smoking: an epidemiological survey in a state hospital | Q42280921 | ||
| Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study | Q42681472 | ||
| Modal subcomponents of metabolic syndrome in patients with bipolar disorder | Q80605996 | ||
| Prevalence of diabetes among Hispanics--selected areas, 1998-2002 | Q80860349 | ||
| Differences in prevalence of obesity among black, white, and Hispanic adults - United States, 2006-2008 | Q84242726 | ||
| Severe mental illness and risk of cardiovascular disease | Q43506112 | ||
| Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone | Q43622360 | ||
| Prevalence of the metabolic syndrome among patients receiving clozapine | Q43622452 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Summary health statistics for U.S. adults: National Health Interview Survey, 2007. | Q44185054 | ||
| The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype | Q44207549 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial | Q44406161 | ||
| Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia | Q44446778 | ||
| Nutritional assessment of patients with schizophrenia: a preliminary study | Q44613832 | ||
| The Effects of an Educational Intervention on Antipsychotic‐Induced Weight Gain | Q44620039 | ||
| Patient and direct-care staff body mass index in a state mental hospital: implications for management | Q44902849 | ||
| The importance of race and ethnic background in biomedical research and clinical practice | Q45024288 | ||
| Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey | Q45218539 | ||
| Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke--United States, 2003. | Q45259599 | ||
| Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. | Q45260554 | ||
| Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. | Q45260562 | ||
| Genders, sexes, and health: what are the connections--and why does it matter? | Q45289784 | ||
| The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia. | Q45378688 | ||
| Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. | Q45900126 | ||
| Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. | Q45917629 | ||
| Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. | Q45919131 | ||
| Affective and cardiovascular effects of experimentally-induced social status. | Q45954600 | ||
| Contribution of major diseases to disparities in mortality | Q46078688 | ||
| A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. | Q46205584 | ||
| Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims | Q46399849 | ||
| Chronic exposure to everyday discrimination and coronary artery calcification in African-American women: the SWAN Heart Study | Q46565622 | ||
| The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. | Q46672305 | ||
| Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. | Q46683011 | ||
| Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. | Q46723525 | ||
| Prevalence of cigarette use among 14 racial/ethnic populations--United States, 1999-2001. | Q47234706 | ||
| Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study | Q47238068 | ||
| Weight gain during a double-blind multidosage clozapine study | Q47305735 | ||
| Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients | Q48114087 | ||
| Bridging the gap between mental and physical health: a multidisciplinary approach. | Q48460111 | ||
| State of disparities in cardiovascular health in the United States | Q50134146 | ||
| Improving health and health care for persons with serious mental illness: the window for US federal policy change. | Q51851025 | ||
| Integrating general health care in private community psychiatry practice. | Q51900607 | ||
| Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. | Q51916505 | ||
| Physical activity patterns in adults with severe mental illness. | Q51925294 | ||
| Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. | Q51944911 | ||
| Integrated medical care for patients with serious psychiatric illness: a randomized trial. | Q51963448 | ||
| Prevalence and correlates of diabetes in national schizophrenia samples. | Q53506906 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies | Q56529982 | ||
| Trends in racial and ethnic-specific rates for the health status indicators: United States, 1990-98 | Q77540208 | ||
| Prevalence of heart disease--United States, 2005 | Q79777260 | ||
| P433 | issue | 2 | |
| P921 | main subject | schizophrenia | Q41112 |
| circulatory system | Q11068 | ||
| P1104 | number of pages | 15 | |
| P304 | page(s) | 233-247 | |
| P577 | publication date | 2013-10-22 | |
| P1433 | published in | Comprehensive Psychiatry | Q15749263 |
| P1476 | title | Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review | |
| P478 | volume | 55 |
| Q92085755 | "That's all Fake": Health professionals stigma and physical healthcare of people living with Serious Mental Illness |
| Q64120957 | An Integrative Program to Reduce Stigma in Primary Healthcare Workers Toward People With Diagnosis of Severe Mental Disorders: A Protocol for a Randomized Controlled Trial |
| Q36804310 | Associations Between Gender and Obesity Among Adults with Mental Illnesses in a Community Health Screening Study |
| Q26743925 | Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications |
| Q47849844 | Bridges to Better Health and Wellness: An Adapted Health Care Manager Intervention for Hispanics with Serious Mental Illness |
| Q90723098 | Correlates of Physical Activity and Cardiorespiratory Fitness in Racially and Ethnically Diverse People with Serious Mental Illness in Supportive Housing |
| Q41093202 | Disease Burden Among Individuals with Severe Mental Illness in a Community Setting. |
| Q30248449 | Disparities at the intersection of marginalized groups |
| Q36772796 | Ethnicity and cardiovascular health inequalities in people with severe mental illnesses: protocol for the E-CHASM study |
| Q35481734 | Evaluation of left ventricular systolic and diastolic functions in bipolar patients during lithium therapy |
| Q37035531 | Health behavior change benefits: Perspectives of Latinos with serious mental illness |
| Q38994958 | How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review |
| Q90860747 | Increased risk of type 2 diabetes among the siblings of patients with schizophrenia |
| Q47643441 | Measuring Recurring Stigma in the Lives of Individuals with Mental Illness. |
| Q35925059 | Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors. |
| Q37721268 | Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? |
| Q36019597 | Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial |
| Q92590492 | Perspectives on diet and physical activity among urban African Americans with serious mental illness |
| Q90040636 | Prioritizing the healthcare needs of Latinos with mental illness |
| Q53436582 | Racial disparities in bipolar disorder treatment and research: a call to action. |
| Q47417985 | Racial/Ethnic Differences in Cigarette Use: The Roles of Mental Illness and Health-Care Access/Utilization |
| Q46197184 | Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico: A Qualitative Study. |
| Q38742210 | Simulations Test Impact Of Education, Employment, And Income Improvements On Minority Patients With Mental Illness |
| Q39649650 | The Role of Diabetes in Predicting Employment Status for Individuals with Bipolar Disorder |
| Q38584846 | The epidemiology of diabetes in psychotic disorders |
| Q47199348 | Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC). |
| Q33834336 | Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross-sectional analysis of 588 408 records from the UK. |
| Q36095835 | Understanding mental health for the prevention and control of cardiovascular diseases |
Search more.